Submit Deal

REGENERON VENTURES

HQ - Greenwich

Summary

Regeneron Ventures is a corporate venture capital fund.

Deals Overview

Total Deals5

Valued Deals5

Total Value£ 443 M

Avg. Deal Size£ 89 M

Market Context

Senior Management

Leonard Schleifer
CEO and President

Sort

12 Jan 2025|United States|Biotechnology

Target: TUNE THERAPEUTICS

Bidder: REGENERON VENTURES

3 Service Providers

1 Target | 2 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 143 M

Value

13 Jan 2025|United States|Biotechnology

Target: NORMUNITY

Bidder: YK BIOVENTURES

5 Service Providers

2 Target | 3 Bidder

4 Dealmakers

2 Target | 2 Bidder

£ 60 M

Value

18 Jun 2025|United States|Biotechnology

Target: ACTIO BIOSCIENCES INC

Bidder: REGENERON VENTURES

4 Service Providers

3 Target | 1 Bidder

3 Dealmakers

2 Target | 1 Bidder

£ 49 M

Value

07 Aug 2025|United States|Biotechnology

Target: STRAND THERAPEUTICS

Bidder: AMGEN VENTURES

3 Service Providers

2 Target | 1 Bidder

2 Dealmakers

1 Target | 1 Bidder

£ 114 M

Value

10 Nov 2025|United States|Biotechnology

Target: IAMBIC THERAPEUTICS

Bidder: REGENERON VENTURES

18 Service Providers

1 Target | 17 Bidder

18 Dealmakers

1 Target | 17 Bidder

£ 75 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy